Belimumab

BENLYSTA 120 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

120 mg polvo para concentrado para solución para perfusiónSpainMarketedAuthorised 10 Aug 2011

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Belimumab

BENLYSTA 120 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

120 mg polvo para concentrado para solución para perfusiónSpainMarketedAuthorised 10 Aug 2011

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Benlysta 120 mg, Poeder voor oplossing voor infusieNetherlands · Poeder voor oplossing voor infusie · GlaxoSmithKline (Ireland) Ltd.

Benlysta 200 mg oplossing voor injectie in voorgevulde penNetherlands · Oplossing voor injectie · GlaxoSmithKline (Ireland) Ltd.

Benlysta 200 mg oplossing voor injectie in voorgevulde spuitNetherlands · Oplossing voor injectie · GlaxoSmithKline (Ireland) Ltd.

BenlystaRomania · 120 mg · pulb. pt. conc. pt. sol. perf. · Glaxosmithkline (Ireland) Limited

BENLYSTA 120mgRomania · 120mg · pulb. pt. conc. pt. sol. perf. · Glaxo Group Limited

BENLYSTA 400mgRomania · 400mg · pulb. pt. conc. pt. sol. perf. · Glaxo Group Limited

Benlysta 120MG Powder for Solution for InfusionSaudi Arabia · Hospira

Benlysta 400MG Powder for Solution for InfusionSaudi Arabia · Hospira

BenlystaSaudi Arabia · Glaxo Operations UK Ltd

Benlysta Powder for Solution for Infusion 120mgSingapore · 120mg/vial · injection, powder, lyophilized, for solution · Glaxosmithkline Pte LTD

Benlysta Powder for Solution for Infusion 400mgSingapore · 400mg/vial · injection, powder, lyophilized, for solution · Glaxosmithkline Pte LTD

BenlystaUnited States · 120MG, 200MG/ML, 400MG · injectable · Human Genome Sciences INC.

BenlystaUnited States · 200MG/ML · Injection · GlaxoSmithKline LLC

Packs

Pack	Code	Status
BENLYSTA 120 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial	683044

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Belimumab
Strength: 120 mg
Dosage form: polvo para concentrado para solución para perfusión
Route: vía intravenosa
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 10 Aug 2011
Registration: 11700001
Marketing authorisation holder: Glaxosmithkline (Ireland) Limited
Procedure: EU centralised
Supply: Uso Hospitalario

Spain